NEW YORK, March 3, 2023 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against certain officers and directors of Fate Therapeutics, Inc. (“Fate” or the “Company”) (NASDAQ: FATE). The class action, filed in the United States District Court for the…
